Form D · Biotechnology
LUMINOPIA, INC.
Cambridge, MA · CIK 0001679733
Offering snapshot reported Jun 29, 2023 · SEC filing
- Reported sold
- $15.8M Offering amount: $16.8M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 16, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 29, 2023 | Initial | $15,811,759 | No comparison | 10 | SEC filing |
| Oct 19, 2022 | Initial | $4,074,997 | No comparison | 15 | SEC filing |
| Dec 13, 2019 | Initial | $11,110,726 | No comparison | 29 | SEC filing |
| Sep 27, 2017 | Initial | $3,625,000 | No comparison | 8 | SEC filing |
| Sep 27, 2017 | Initial | $1,250,000 | No comparison | 3 | SEC filing |
| Dec 14, 2016 | Initial | $410,000 | No comparison | 8 | SEC filing |
| Jul 15, 2016 | Initial | $250,000 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-485522
The total offering amount and amount sold includes $1,212,497 representing the conversion of outstanding convertible securities.
Source: Form D, filed Jun 29, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| William Dai | Director |
| Mark Dockser | Executive |
| Jeffrey Dunn | Director |
| Joi Ito | Director |
| Mark Jacobstein | Director |
| Robert Langer | Director |
| Michelle Lee | Director |
| Casey Tansey | Director |
| Dean Travers | Director |
| Alexander Wendland | Director, Executive |
| Scott Xiao | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
625 Massachusetts Avenue Floor 2
Cambridge, MA, 02139
Cambridge, MA, 02139